A Johns Hopkins scientist was known for rigorous studies of psychedelics. Was he a true believer?

As historic MDMA decision nears, even J.P. Morgan eyes psychedelic investments

New Research Grants Push Psychedelic Studies Beyond Therapeutics

Investors pile into psychedelic drug start-ups tackling mental health

Massachusetts Lawmakers Approve Psilocybin Bill To Legalize For ‘Therapeutic, Spiritual And Medicinal Purposes’

The Working Woman’s Newest Life Hack: Magic Mushrooms

As investors pile into psychedelics, idealism gives way to pharma economics

What Does Being Sober Mean Today? For Many, Not Full Abstinence.

Idealism gives way to pharma economics as investors rush into psychedelic market

Your employer may be adding another health benefit to its roster: psychedelic drugs